Android app Apple app link

Alnylam Pharmaceuticals, Inc. (ALNY) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$313.12
Day's range
$323.68

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
02/12/2026 Stifel Nicolaus Paul Matteis $444.00 $313.05   41.83%
01/12/2026 Raymond James Martin Auster $472.00 $398.29   18.51%
12/15/2025 Leerink Partners Mani Foroohar $351.00 $399.42   -12.12%
11/04/2025 H.C. Wainwright Patrick Trucchio $570.00 $434.07   31.32%
10/31/2025 Oppenheimer Leland Gershell $500.00 $449.56   11.22%
10/31/2025 Chardan Capital Keay Nakae $475.00 $449.56   5.66%
10/30/2025 Morgan Stanley Michael Ulz $495.00 $449.56   10.11%
10/06/2025 Morgan Stanley Michael Ulz $475.00 $456.35   4.09%
10/06/2025 Stifel Nicolaus Paul Matteis $495.00 $456.35   8.47%
09/05/2025 BMO Capital Kostas Biliouris $470.00 $452.81   3.8%
07/21/2025 Truist Financial Danielle Brill $385.00 $324.49   18.65%
06/24/2025 BMO Capital Kostas Biliouris $360.00 $325.00   10.77%
01/07/2025 Bernstein William Pickering $310.00 $235.95   31.38%
10/24/2024 Canaccord Genuity Whitney Ijem $336.00 $294.87   13.95%
10/01/2024 Canaccord Genuity Whitney Ijem $366.00 $273.69   33.73%
09/27/2024 Bank of America Securities Tazeen Ahmad $307.00 $274.91   11.67%
08/27/2024 BMO Capital Kostas Biliouris $300.00 $269.31   11.4%
08/26/2024 RBC Capital Luca Issi $300.00 $271.43   10.53%
08/16/2024 Goldman Sachs Salveen Richter $370.00 $262.70   40.85%
07/08/2024 Canaccord Genuity Whitney Ijem $357.00 $253.86   40.63%
06/28/2024 UBS Esther Rajavelu $288.00 $247.00   16.6%
06/27/2024 RBC Capital Luca Issi $265.00 $245.17   8.09%
06/27/2024 Stifel Nicolaus Paul Matteis $295.00 $247.40   19.24%
06/25/2024 Evercore ISI Liisa Bayko $260.00 $222.90   16.64%
06/25/2024 RBC Capital Luca Issi $250.00 $222.90   12.16%
06/24/2024 Morgan Stanley Andrew Galler $250.00 $224.70   11.26%
06/24/2024 H.C. Wainwright Patrick Trucchio $400.00 $227.05   76.17%
06/24/2024 Stifel Nicolaus Paul Matteis $247.00 $227.92   8.37%
06/12/2024 RBC Capital Luca Issi $235.00 $156.43   50.23%
04/08/2024 BMO Capital Kostas Biliouris $234.00 $156.59   49.43%
12/15/2022 Piper Sandler Edward Tenthoff $253.00 $229.37   10.3%
07/12/2022 Cantor Fitzgerald Olivia Brayer $175.00 $145.85   19.99%
06/14/2022 Piper Sandler Edward Tenthoff $208.00 $135.83   53.14%
02/10/2022 BMO Capital Gary Nachman $175.00 $150.76   16.08%
02/10/2022 Berenberg Bank Zhiqiang Shu $154.00 $150.76   2.15%
02/09/2022 RBC Capital Luca Issi $225.00 $150.86   49.14%
02/02/2022 Guggenheim Debjit Chattopadhyay $170.00 $142.51   19.29%
01/25/2022 Bank of America Securities Tazeen Ahmad $209.00 $130.12   60.62%
01/22/2022 Jefferies Maury Raycroft $205.00 $136.53   50.15%
12/12/2021 Cowen & Co. Ritu Baral $250.00 $186.42   34.11%
11/21/2021 Goldman Sachs Salveen Richter $273.00 $187.01   45.98%
10/28/2021 Evercore ISI Maneka Mirchandaney $190.00 $159.56   19.08%
10/28/2021 Cantor Fitzgerald Alethia Young $275.00 $159.56   72.35%
10/28/2021 UBS Esther Rajavelu $211.00 $159.56   32.24%
10/27/2021 Barclays Gena Wang $210.00 $162.14   29.52%

Alnylam Pharmaceuticals Inc FAQ's

Alnylam Pharmaceuticals Inc has been rated by research analysts at Morgan Stanley, Bernstein, Canaccord Genuity, Chardan Capital, Stifel Nicolaus, H.C. Wainwright in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.